Glenmark Pharmaceuticals Inc., USA has announced that it will launch Leucovorin Calcium for Injection USP, 350 mg per single dose vial, in December 2025.Leucovorin...
Drugmaker Zydus Lifesciences Ltd. has received final approval from the United States Food and Drug Administration (USFDA) for its Leuprolide Acetate injection, the company...
Glenmark Pharmaceuticals Ltd. on Tuesday, November 4, said its US-based arm will launch the 8.4% Sodium Bicarbonate Injection USP, which is recommended for controlling...